---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-089138"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2026-08-13T20:25:42+00:00"
generated_at: "2026-08-13T20:27:17.921597+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical Q2 revenue up 127% to $1.3M; net loss $4.1M; closes $4.2M offering

## Summary
- Q2 revenue $1.3M (+127% YoY); gross profit $0.8M (64% margin vs 43% in Q2 2025).
- Net loss $4.1M ($12.35/share) vs $2.8M ($12.76/share) in Q2 2025; cash $1.7M at June 30.
- Closed $4.2M public offering July 1, net ~$3.6M; partial repayment of $5.2M convertible notes due Sept 11, 2026.
- FDA 510(k) clearance for Catamaran SI Joint Fusion System; record July case volume after 98% training-event increase.
- Effected 1-for-35 reverse stock split Aug 10; working to regain Nasdaq minimum bid price compliance.

## SEC filing metadata
- accession: 0001213900-26-089138
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2026-08-13T20:25:42+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/0001213900-26-089138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/ea0301935-8k_tenon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-089138
- JSON: https://secwatch.observer/filing/0001213900-26-089138.json
- Plain text: https://secwatch.observer/filing/0001213900-26-089138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.